example muln… yeah short companies/ sorry scam companies.
Shantou Institute of Ultrasonic Instrument
301602
Hubei Sinophorus Electronic Materials
688545
Pansoft
300996
4
Jiayu Holding
300117
5
Wuxi Taclink Optoelectronics Technology
688205
US Stock MarketDetailed Quotes
VOR Vor Biopharma
- 1.350
- -0.010-0.74%
Trading Jan 22 12:51 ET
168.14MMarket Cap-0.82P/E (TTM)
1.480High1.340Low336.07KVolume1.380Open1.360Pre Close472.35KTurnover0.87%Turnover RatioLossP/E (Static)124.54MShares2.50052wk High2.30P/B52.27MFloat Cap0.63052wk Low--Dividend TTM38.72MShs Float63.620Historical High--Div YieldTTM10.29%Amplitude0.630Historical Low1.405Avg Price1Lot Size
Vor Biopharma Stock Forum
Sign in to post a comment
$Vor Biopharma (VOR.US)$ Im keep loading, bit by bit.
2
2
$Vor Biopharma (VOR.US)$ Incoming 🚀🚀🚀
2
3
$Vor Biopharma (VOR.US)$ be quiet.. slow slow slowly
2
$Vor Biopharma (VOR.US)$ Its time.
1
1
$Vor Biopharma (VOR.US)$
Was watching this Friday painting a beautiful chart not sure why I didn't enter but I will likely enter Monday.
Was watching this Friday painting a beautiful chart not sure why I didn't enter but I will likely enter Monday.
2
4
$Vor Biopharma (VOR.US)$ be quiet 🤫🤫🤫
1
4
$Vor Biopharma (VOR.US)$
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback from FDA Regarding Registrational Trial Design
• Preliminary data suggests improved relapse-free survival compared to published groups of acute myeloid leukemia (AML) patients at high risk of relapse post-transplant
• Trem-cel + Mylotarg continue to demonstrate engraftment, shielding, and broadened therapeutic window
...
2
1
$Vor Biopharma (VOR.US)$ Reuters· 1 min ago
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design
Vor Bio Provides Clinical Update Further Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies; Receives Supportive Feedback From FDA Regarding Registrational Trial Design
1
$Vor Biopharma (VOR.US)$ 2.8 ////
2
3
No comment yet
Trending Stocks
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Stocks & Industries to Watch Under Trump's Second Presidency
Key takeaways Tech stocks underwent substantial growth due to tax cuts and reduced corporate regulations in Trump's first term along with defense and aerospace
Discussing
U.S.-China talks spark interest, no more inflation?
🎙️Discussion: 1. How will Trump's China policies affect Chinese assets? 2. Which sectors might benefit as U.S. inflation risks decline?
Moomoo News Global
Dec 9, 2024 20:23
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011
72576952 : im in from . o,75
小竜 OP 72576952 : Superb